Imagine a vast library of genetic information where countless pages, once dismissed as irrelevant scribbles, suddenly reveal hidden messages critical to understanding human health. This is the reality scientists are confronting as they delve into the genome's so-called "junk DNA," regions long
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, as well as a deep understanding of technology and innovation in the industry. Today, we’re diving into a groundbreaking study on AI and hidden diabetes risk, exploring how
In an era where scientific breakthroughs demand speed, precision, and scalability, Ginkgo Bioworks stands at the forefront of a transformative movement in the biotech industry by harnessing artificial intelligence (AI) to redefine lab automation. With the global lab automation market currently
What if the erratic rhythm of millions of hearts could be decoded not by a stethoscope, but by the raw power of supercomputers? Atrial fibrillation (AF), the most common type of irregular heartbeat, silently threatens lives worldwide, often leading to devastating strokes. This condition,
Imagine a world where millions of people struggle with high cholesterol, a silent threat that fuels heart disease, yet many cannot tolerate standard treatments like statins due to side effects or poor response, leaving them at risk. This pressing challenge affects countless lives, with
Imagine a world where complex cardiac arrhythmias, conditions that disrupt the heart's rhythm and pose significant health risks, can be diagnosed and treated with unprecedented precision and safety. This vision is becoming a reality with the recent U.S. Food and Drug Administration (FDA) clearance
